تقرير
أعرض في EDS

Fungemia Due to Saprochaete capitata in a Non-Neutropenic Critically Ill Patient.

التفاصيل البيبلوغرافية
العنوان: Fungemia Due to Saprochaete capitata in a Non-Neutropenic Critically Ill Patient.
المؤلفون: Mawad TN; Infectious Diseases, King Saud University, Riyadh, SAU., Alfaifi RA; Infectious Diseases, King Saud University, Riyadh, SAU., Almazyed OM; Infectious Diseases, King Saud University, Riyadh, SAU., Alhumaidi RA; Internal Medicine, King Saud University, Riyadh, SAU., Alsubaie AM; Infectious Diseases, King Saud University, Riyadh, SAU.
المصدر: Cureus [Cureus] 2023 Dec 27; Vol. 15 (12), pp. e51147. Date of Electronic Publication: 2023 Dec 27 (Print Publication: 2023).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Saprochaete capitata is an uncommon yeast species; its impact on non-neutropenic patients appears to be on the rise. We describe a case of S. capitata fungemia in a critically ill end-stage kidney disease (ESKD) patient on peritoneal dialysis. The patient presented with mesenteric ischemia and underwent several laparotomies during hospitalization. His hospital stay was complicated as fungemia developed and spread to multiple sites, which resulted in severe complications and ultimately led to fatal outcomes. S. capitata 's diagnostic delay is a concern, but matrix-assisted laser desorption/Ionization time-of-flight (MALDI-TOF) mass spectrometry may help provide accurate identification. Our case highlights the need for prompt diagnosis and tailored antifungal therapy, especially when managing this challenging infection in immunocompromised patients.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Mawad et al.)
References: Med Mycol. 2011 May;49(4):414-8. (PMID: 21105848)
J Investig Med High Impact Case Rep. 2018 Aug 21;6:2324709618795268. (PMID: 30151397)
Hematol Rep. 2022 Mar 24;14(2):67-72. (PMID: 35466175)
J Antimicrob Chemother. 2020 May 1;75(5):1194-1205. (PMID: 32025716)
Infection. 2015 Apr;43(2):211-5. (PMID: 25078793)
Pathogens. 2020 Nov 07;9(11):. (PMID: 33171713)
Front Microbiol. 2020 Jan 31;11:84. (PMID: 32082293)
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:76-98. (PMID: 24102785)
Lancet Infect Dis. 2021 Dec;21(12):e375-e386. (PMID: 34419208)
Cureus. 2023 Sep 19;15(9):e45568. (PMID: 37868573)
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:76-85. (PMID: 14748804)
فهرسة مساهمة: Keywords: a case report; antifungal therapy; disseminated fungemia; magnusiomyces capitatus; non-candida yeast; non-neutropenic patient; saprochaete capitata
تواريخ الأحداث: Date Created: 20231228 Latest Revision: 20231229
رمز التحديث: 20231229
مُعرف محوري في PubMed: PMC10751558
DOI: 10.7759/cureus.51147
PMID: 38152295
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.51147